ILMAC 2005

Inustry Exhibition for Research and Development, Environmental and Process Technology in Pharmaceuticals, Chemicals and Biotechnology The new ILMAC will take place at Basel Exhibition, Hall 1, from May 24 to May 27, 2005.

Start Date 24.05.2005 - 09:00
Event End 27.05.2005 - 17:00
Location Universität Basel

Confirmed Speakers:

  • Hans Joachim Güntherodt, (Institut für Physik, Universität Basel), «New Tools in Nanosciences for Biodiagnostics and Bioapplication»
  • Martin Hegner, (Institut für Physik, Universität Basel; Träger des Wissenschaftspreises der Stadt Basel), «Multifunctional Cantilever Arrays for Chemical and Biological Sensing»
  • Emmanuel Delamarche, (IBM Zürich, Research Laboratory) «Soft Lithography for Bioanalytical applications»
  • Chyi-Cheng Chen, (DMS LTD, Basel) «Vitamin E Nanoparticle for Beverage Application»
  • Hans Peter Märki, (F. Hoffmann- La Roche LTD. Basel; Präsident der Division Medizinische Chemie der SCG), «The Fate of Drugs in the Body – Mechanism and Predictions for Uptake, Distribution and Eilimation of Pharmaceuticals»
  • Jean- Michel Scherrmann, (Hôpital Fernand Widal, Paris), «Expression and Functional Role of Multidrug Resistance Transporters at the Blood Brain Barrier»
  • Jörg Huwyler, (F. Hoffmann- La Roche LTD. Basel), «Relevance of P-glycoprotein for the Development of CNS Compounds»
  • Alex Avdeef, (pION Inc., Boston), «Physico-Chemical Profiling of Drug Candidates»
  • Bernhard Faller (Novartis Pharma AG, Basel) «Combination of In-Silico and Experimental Approaches in Lead Discovery Profiling»
  • Jean-Paul Clozel, (CEO of Actelion Pharmaceuticals Ltd.), «Actelion: A New Global Player in the Biotech Industry?»
  • Beat Wipf, (F. Hoffmann- La Roche LTD. Basel), «From Proteomics to Systems Biology»
  • Bruno Domon, (ETH Zürich), «Systems Biology and New MS Techniques in Quantitative Proteomics»
  • Jan van Oostrum, (Novartis Pharma AG Basel) «Proteomics for Drug Discovery»
  • Hanno Langen, (F. Hoffmann-La Roche LTD. Basel), «Biomarkers Discovery and Clinical Validation»
  • Matthias Böse, (Bruker Optics GmbH, Ettlingen) «Biopharmaceutical Formulations Studied by FT-IR»
  • Georg Frater, (Givaudan Schweiz AG, Dübendorf; Präsident der SCG), «Trends in Bioanalysis: Nuclear Magnetic Resonancespectroscopy and Mass Spectroscopy»
  • Hans Senn, (F. Hoffmann-La Roche LTD. Basel), «Metabolomics: Metabolic Profiles and Biomarkers in Pharma Research»
  • Till Kühn, (Bruker Biospin AG, Fällanden), «NMR – Modern Routine Analysis in Industry»
  • Markus Rudin, (Novartis AG, Institute for Biomedical Research, Basel) «NMR Imaging in Drug Discovery – From Anatomical Structures to Molecular Interactions»
  • Adelbert Roscher, (Universität München), «High-Content Screening of the Metabolome by Quantitative MS-MS»
  • Kurt Wüthrich, (Nobelpreisträger für Chemie (2002)), «The NMR View of Proteins – From Structural Biology to Structural Genomics»